Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 2
2001 1
2002 1
2003 1
2004 1
2005 2
2006 3
2007 2
2008 1
2009 1
2010 2
2012 1
2013 5
2014 6
2015 5
2016 1
2017 1
2019 2
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.
Phi XA, Houssami N, Hooning MJ, Riedl CC, Leach MO, Sardanelli F, Warner E, Trop I, Saadatmand S, Tilanus-Linthorst MMA, Helbich TH, van den Heuvel ER, de Koning HJ, Obdeijn IM, de Bock GH. Phi XA, et al. Among authors: Obdeijn IM. Eur J Cancer. 2017 Nov;85:31-38. doi: 10.1016/j.ejca.2017.07.055. Eur J Cancer. 2017. PMID: 28886475 Review.
Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature.
Drooger JC, Hooning MJ, Seynaeve CM, Baaijens MH, Obdeijn IM, Sleijfer S, Jager A. Drooger JC, et al. Among authors: Obdeijn IM. Cancer Treat Rev. 2015 Feb;41(2):187-96. doi: 10.1016/j.ctrv.2014.12.002. Epub 2014 Dec 8. Cancer Treat Rev. 2015. PMID: 25533736 Review.
Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis.
Phi XA, Houssami N, Obdeijn IM, Warner E, Sardanelli F, Leach MO, Riedl CC, Trop I, Tilanus-Linthorst MM, Mandel R, Santoro F, Kwan-Lim G, Helbich TH, de Koning HJ, Van den Heuvel ER, de Bock GH. Phi XA, et al. Among authors: Obdeijn IM. J Clin Oncol. 2015 Feb 1;33(4):349-56. doi: 10.1200/JCO.2014.56.6232. Epub 2014 Dec 22. J Clin Oncol. 2015. PMID: 25534390
MARIBS study.
Tilanus-Linthorst MM, Obdeijn IM, Bartels KC. Tilanus-Linthorst MM, et al. Among authors: Obdeijn IM. Lancet. 2005 Jul 23-29;366(9482):291-2. doi: 10.1016/S0140-6736(05)66980-2. Lancet. 2005. PMID: 16039329 No abstract available.
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).
Saadatmand S, Obdeijn IM, Rutgers EJ, Oosterwijk JC, Tollenaar RA, Woldringh GH, Bergers E, Verhoef C, Heijnsdijk EA, Hooning MJ, de Koning HJ, Tilanus-Linthorst MM. Saadatmand S, et al. Among authors: Obdeijn IM. Int J Cancer. 2015 Oct 1;137(7):1729-38. doi: 10.1002/ijc.29534. Epub 2015 Apr 17. Int J Cancer. 2015. PMID: 25820931 Free article. Clinical Trial.
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S, Geuzinge HA, Rutgers EJT, Mann RM, de Roy van Zuidewijn DBW, Zonderland HM, Tollenaar RAEM, Lobbes MBI, Ausems MGEM, van 't Riet M, Hooning MJ, Mares-Engelberts I, Luiten EJT, Heijnsdijk EAM, Verhoef C, Karssemeijer N, Oosterwijk JC, Obdeijn IM, de Koning HJ, Tilanus-Linthorst MMA; FaMRIsc study group. Saadatmand S, et al. Among authors: Obdeijn IM. Lancet Oncol. 2019 Aug;20(8):1136-1147. doi: 10.1016/S1470-2045(19)30275-X. Epub 2019 Jun 17. Lancet Oncol. 2019. PMID: 31221620 Clinical Trial.
Preoperative prediction of cosmetic results in breast conserving surgery.
Vos EL, Koning AH, Obdeijn IM, van Verschuer VM, Verhoef C, van der Spek PJ, Menke-Pluijmers MB, Koppert LB. Vos EL, et al. Among authors: Obdeijn IM. J Surg Oncol. 2015 Feb;111(2):178-84. doi: 10.1002/jso.23782. Epub 2014 Oct 20. J Surg Oncol. 2015. PMID: 25332158
38 results
Jump to page
Feedback